Congress | NACDS

Patients, Consumers, the Underserved, Healthcare Providers and Public Health Call on Congress to Fix a Missing Link So Pharmacies Can Ramp Up COVID Testing and Prepare for Vaccinations Patient groups urging action in next COVID bill represent 200 million Americans living with cancer, cardiovascular disease, HIV, mental health issues, liver disease, lupus and other conditions

admin2020-08-06T14:58:55-04:00Categories: Press Release|Tags: Congress, Preparedness, Vaccinations|

Patient groups urging action in next COVID bill represent 200 million Americans living with cancer, cardiovascular disease, HIV, mental health issues, liver disease, lupus and other conditions.

NACDS Emphasizes Productive Pharmacist-Physician Partnership and Need for Congress to Advance COVID Testing Services, Expresses Disappointment in AMA’s Lobbying NACDS issues an open letter to Congress urging a necessary step to help scale and sustain COVID-19 testing

admin2020-07-22T15:57:56-04:00Categories: Press Release|Tags: Congress, Preparedness, Provider_Status|

NACDS issues an open letter to Congress urging a necessary step to help scale and sustain COVID-19 testing.

NACDS Board Continues Crucial Engagement with Key Leaders of Congress, the Administration in “Virtual” D.C. Fly-in

admin2020-06-24T15:44:14-04:00Categories: Article, Press Release|Tags: Congress, Preparedness, RxIMPACT|

On June 24, the NACDS Board of Directors “virtually” met with eight key members of the Administration and Congress.

More than 240 Patient, Healthcare Groups Urge Congress to Reform Pharmacy “DIR Fees” This Year Congress “should not overlook the clear and present opportunity” to address reforms

admin2020-05-08T14:24:07-04:00Categories: Press Release|Tags: Congress, DIR, Reimbursement|

More than 240 entities urged Congressional leaders to act on a key reform to lower patients’ prescription drug prices at the pharmacy counter and to help prevent pharmacy closures that jeopardize access.

Federal Policymaking Can Help Pharmacies Ensure Access to Essential Care Amid COVID-19, NACDS Says Letter to Congress, Administration urges immediate steps “to further optimize the critical role pharmacy plays in helping to respond to this national emergency”

admin2020-03-17T11:39:24-04:00Categories: Press Release|Tags: Congress, Preparedness, Provider_Status, Vaccinations|

Letter to Congress, Administration urges immediate steps “to further optimize the critical role pharmacy plays in helping to respond to this national emergency”

NACDS Op-ed in Morning Consult: DIR Fees “as Damaging to Patients and Pharmacies as Advertised” Congressional action urged as Drug Channels Institute analysis shows fees “have grown faster than most people realize” and reached a record $9.1 billion in 2019

admin2020-02-26T12:52:02-05:00Categories: Press Release|Tags: Congress, DIR, Public_Relations, Reimbursement|

NACDS' opinion piece cites a Drug Channels Institute analysis that DIR fees “have grown faster than most people realize” and reached a record $9.1 billion in 2019.

Next Generation Turning Out for NACDS’ Signature Grassroots Event Record-Level of Colleges, Schools of Pharmacy Participating in 2020 NACDS RxIMPACT Day on Capitol Hill

admin2020-01-16T09:13:57-05:00Categories: Article|Tags: Congress, RxIMPACT|

A record-breaking 57 campuses will be represented by 60 student pharmacists at the 2020 NACDS RxIMPACT Day on Capitol Hill.

Senate Finance Committee Wages Bipartisan Effort Across Branches of Government to Relieve Patients and Pharmacies from Pharmacy DIR Fees Pharmacy welcomes letter from over 80 percent of Committee members to Trump Administration, urging closure of Medicare regulatory loophole as legislative push continues

admin2019-09-12T13:01:36-04:00Categories: Press Release|Tags: Congress, DIR, Medicare, Reimbursement|

Pharmacy welcomes letter from over 80 percent of Committee members to Trump Administration, urging closure of Medicare regulatory loophole as legislative push continues

Highly Productive August for NACDS RxIMPACT

admin2019-08-30T11:59:57-04:00Categories: Article|Tags: Congress, DIR, RxIMPACT|

Many recent NACDS RxIMPACT pharmacy tours have been directly with members of Congress themselves—68 percent so far this year.

Pharmacy Tours Highlight Vital Need for DIR Fee Relief

admin2019-08-23T11:34:42-04:00Categories: Article|Tags: Congress, DIR, Reimbursement, RxIMPACT|

The total number of NACDS RxIMPACT 2019 in-district events to promote DIR relief priorities now stands at 72—and counting.

National Association of Chain Drug StoresPharmacies. The face of neighborhood healthcare.